David Ahlquist, MD, Gastroenterology, Rochester, MN

DavidAAhlquistMD

Gastroenterology Rochester, MN

Professor, Internal Medicine, Mayo Medical School

Dr. Ahlquist is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ahlquist's full profile

Already have an account?

Education & Training

  • Harvard Business School
    Harvard Business SchoolBusiness School Executive Course, 2004
  • Columbia University
    Columbia UniversityExecutive Education Course, 2004
  • Mayo School of Graduate Medical Education
    Mayo School of Graduate Medical EducationFellowship, Gastroenterology, 1980 - 1983
  • Mayo School of Graduate Medical Education
    Mayo School of Graduate Medical EducationResidency, Internal Medicine, 1977 - 1980
  • Mayo Clinic School of Medicine
    Mayo Clinic School of MedicineClass of 1977
  • University of Minnesota
    University of MinnesotaBA, Summa Cum Laude, 1970 - 1973

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1978 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Research Career Achievement Award Department of Internal Medicine, Mayo Clinic, 2013
  • Clinical Collaborator Award Department of Laboratory Medicine and Pathology, Mayo Clinic, 2012
  • Carol M. Gatton Professorship in Digestive Disease Research Mayo Clinic, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Methylated eyes absent 4 (EA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: Evidence for a field effect  
    Kisiel JB, Garrity-Park MM, Taylor WR, Smyrk TC, Ahlquist DA, Inflamm Bowel Dis, 1/1/2013
  • Aberrantly methylated gene marker levels in stool: effect of demographic exposure, body mass, and other patient characteristics  
    Ahlquist DA, Taylor WR, Yab TC, Devens ME, Mahoney DW, Boardman LA, Thibodeau SN, Zou H, Domanico MJ, Berger BM, Lidgard GP, J Mol Biomark Diagn, 9/4/2012
  • New generation molecular stool testing: a rational step toward eradication of colorectal cancer  
    Ahlquist DA, AGA Perspectives, 1/1/2012
  • Join now to see all

Lectures

  • The Ninth Annual Meeting of the International Society of Gastrointestinal Oncology 
    The Johns Hopkins University School of Medicine, Arlington, Virginia - 9/13/2012

Press Mentions

  • A Pair of PE Partnerships & More: 8 GI Industry Key Notes
    A Pair of PE Partnerships & More: 8 GI Industry Key NotesDecember 11th, 2019
  • Cologuard Co-Inventor Named Fellow of National Academy of Inventors — 3 Insights
    Cologuard Co-Inventor Named Fellow of National Academy of Inventors — 3 InsightsDecember 5th, 2019
  • Researcher Challenges Her Team to Develop Solution for DRC Health Crisis
    Researcher Challenges Her Team to Develop Solution for DRC Health CrisisAugust 7th, 2019
  • Join now to see all

Grant Support

  • Colorectal Cancer Screening: Fecal Blood VS DNANational Center For Research Resources2005
  • Colorectal Cancer Screening: Fecal Blood Vs. DNANational Center For Research Resources2004
  • Colorectal Cancer Screening: Fecal Blood VS DNANational Cancer Institute2004
  • Colorectal Cancer Screening--Fecal Blood VS DNANational Cancer Institute2001–2003
  • Fecal Colonocyte Screening For Colorectal NeoplasiaNational Cancer Institute1996–2000
  • Hemoquant Detection Of Colorectal NeoplasiaNational Cancer Institute1985–1990